$ATI

Fields Kimberly A sold $5.7M of ATI

Fields Kimberly A (Chair, President and CEO) sold 24,845 shares of ATI INC (ATI) at an average of $231.19 ($228.32–$232.43, $5.74M total) across 5 trades on 2026-08-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Fields Kimberly A
Published Aug 19, 2026, 9:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 19, 2026, 9:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ATI
Bearish
medium confidence
Mentioned
$ATI
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATIBearishLow
01

Why it matters

The disclosed sale may influence short‑term sentiment but is unlikely to drive long‑term price movement.

02

Market read

Insider sell of $5.7M by ATI's CEO, a material but not market‑moving event.

03

What to watch

Potential upcoming capital raise or strategic transaction that prompted the insider to diversify holdings.

Relevance 5/10Novelty 7/10Timing: filed 2026‑08‑19, reflects sale on 2026‑08‑17

Background

Form 4 filings disclose insider transactions; a 10b5‑1 plan allows pre‑scheduled sales.

Company-level read

Ticker impact

$ATIBearishMedium confidence
Context

CEO Fields sold $5.7M of ATI shares via a 10b5‑1 plan on 2026‑08‑17.

Expected impact

Potential short‑term downward pressure on ATI stock.

Evidence & confidence

The sale represents 4.3% of the insider's post‑transaction holdings and is sizable for a single day, but it follows a pre‑arranged plan, limiting immediate informational advantage.

Market effects

Minimal; the sale does not affect the broader specialty metals sector.

Limited to U.S. investors tracking insider activity.

Low; no cross‑border implications.

Counterpoint

The sale could be purely liquidity‑driven under a 10b5‑1 plan, not a bearish signal.

Key entities

  • Fields Kimberly A

    Chair, President and CEO of ATI Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATIMed

Here's How Much a $1000 Investment in ATI Made 10 Years Ago Would Be Worth Today

ATI Inc., a Pittsburgh-based specialty materials producer, restructured in 2013 and 2020, focusing on High-Performance Materials & Components and Advanced Alloys & Solutions. In Q1 2026, earnings beat estimates but revenues missed. The company benefits from aerospace and defense demand but faces risks from production ramps and supply-chain issues.

$ATIHighAI 9/10

ATI (ATI) Q2 2026 Earnings Call Transcript

ATI reported Q2 2026 results in an earnings call. Revenue rose 11% to $1,261.1 million, with adjusted EBITDA up 37% to $284.4 million and margin expanding to 22.6%. Backlog reached a record $4.4 billion. Adjusted EPS was $1.23. Full-year 2026 guidance: adjusted EBITDA $1.135B-$1.185B and adjusted EPS $4.90-$5.18.

$ATIMedAI 9/10

ATI (ATI) Shares Skyrocket, What You Need To Know

ATI reported Q2 sales of $1.26B, up 10.6% year over year and 3.4% above forecasts, with adjusted EPS of $1.23, 18.3% above expectations. Operating margin rose to 17.4% from 14.1%. Shares rose 11.7% in the afternoon. The article also notes ATI’s stock volatility and recent macro-driven moves.

$ATIHighAI 9/10

ATI Boosts FY26 Outlook; Shares Up 5.3% - Update

ATI, Inc. (ATI) reported second-quarter results and raised guidance. It expects third-quarter adjusted EPS of $1.3198 to $1.37 and fiscal 2026 adjusted EPS of $4.90 to $5.18, up from $4.20 to $4.48. ATI attributed the increase to contracted pricing improvements, a richer product mix, and higher production volumes. Shares were up about 5.3% pre-market.

$ATIMedAI 8/10

ATI (NYSE:ATI) Delivers Strong Q2 CY2026 Numbers, Stock Soars

ATI (NYSE:ATI) reported Q2 CY2026 results. Revenue rose 10.6% year on year to $1.26 billion, exceeding Wall Street estimates by 3.4%. Non-GAAP profit was $1.23 per share, 18.3% above consensus. Adjusted EBITDA margin expanded to 22.6%, and backlog reached a record $4.4 billion. The stock rose 6.3% to $218.00 after the report.